Natera (NTRA) director and co-founder discloses stock gift and sales

Rhea-AI Filing Summary

A Natera, Inc. director and co‑founder reported recent changes in their holdings of the company’s common stock. On December 15, 2025, they donated 1,060 shares as a charitable contribution at a reported price of $0.

On December 17, 2025, they sold 1,592, 1,348 and 130 shares in separate transactions at weighted average prices of $226.5404, $227.4355 and $228.2831 per share, effected under a Rule 10b5‑1 trading plan adopted on December 11, 2024. After these transactions, the reporting person directly beneficially owned 222,966 shares, with an additional 23,282 shares held in each of two Caraluna trusts for beneficiaries, over which they disclaim beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sheena Jonathan

(Last) (First) (Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN TX 78753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			CO-FOUNDER

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2025		G		1,060(1)	D	$0	226,036	D
Common Stock	12/17/2025		S		1,592(2)	D	$226.5404(3)	224,444	D
Common Stock	12/17/2025		S		1,348(2)	D	$227.4355(4)	223,096	D
Common Stock	12/17/2025		S		130(2)	D	$228.2831(5)	222,966	D
Common Stock								23,282	I	By Caraluna 1 Trust(6)
Common Stock								23,282	I	By Caraluna 2 Trust(6)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a charitable contribution by the Reporting Person.

2. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024.

3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.94 to $226.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.96 to $227.84 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.98 to $228.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

	/s/ Vincent Fontanilla, Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did Natera (NTRA) report here?

The filing shows a charitable contribution of 1,060 shares of Natera common stock on December 15, 2025, followed by sales of 1,592, 1,348 and 130 shares in separate transactions on December 17, 2025.

Were the Natera (NTRA) stock sales made under a Rule 10b5-1 plan?

Yes. The filing states that the December 17, 2025 sales were effected pursuant to a Rule 10b5‑1 trading plan adopted by the reporting person on December 11, 2024.

How many Natera (NTRA) shares does the reporting person now hold directly?

After the reported transactions, the reporting person directly beneficially owned 222,966 shares of Natera common stock.

At what prices were the Natera (NTRA) shares sold?

The shares sold on December 17, 2025 had weighted average prices of $226.5404, $227.4355 and $228.2831 per share, with each sale executed across multiple trades within stated price ranges.

What is the relationship of the reporting person to Natera (NTRA)?

The reporting person is identified as a director of Natera and as an other related person specified as a co‑founder.

What are the Caraluna 1 and Caraluna 2 Trust holdings mentioned for Natera (NTRA)?

The filing lists 23,282 shares of Natera common stock held by each of the Caraluna 1 Trust and Caraluna 2 Trust for the benefit of their beneficiaries, and notes that the reporting person disclaims beneficial ownership of those securities.